• 1
    Kupferberg H. Animal models used in the screening of antiepileptic drugs. Epilepsia 2001;42(suppl 4):712.
  • 2
    Loscher W. Animal models of intractable epilepsy. Prog Neurobiol 1997;53: 23958.
  • 3
    Durand D. Ictal patterns in experimental models of epilepsy. J Clin Neurophysiol 1993;10: 28197.
  • 4
    Wallace SJ. A comparative review of the adverse effects of anticonvulsants in children with epilepsy. Drug Saf 1996;15: 37893.
  • 5
    Perucca E, Gram L, Avanzini G, et al. Antiepileptic drugs as a cause of worsening seizures. Epilepsia 1998;39: 517.
  • 6
    Guerrini R, Dravet C, Genton P, et al. Lamotrigine and seizure aggravation in severe myoclonic epilepsy. Epilepsia 1998;39: 50812.
  • 7
    Quilichini PP, Diabira D, Chiron C, et al. Persistent epileptiform activity induced by low Mg2+ in intact immature brain structures. Eur J Neurosci 2002;16: 85060.
  • 8
    Mody I, Lambert JD, Heinemann U. Low extracellular magnesium induces epileptiform activity and spreading depression in rat hippocampal slices. J Neurophysiol 1987;57: 86988.
  • 9
    Levy RH, Mattson RH, Meldrum BS. Antiepileptic drugs. New York : Raven Press, 1995.
  • 10
    Froscher W, Kramer G, Schmidt D, et al. [Serum concentration of anticonvulsants: practical guidelines for measuring and useful interpretation. Therapy Committee of the German Section of the International Epilepsy League]. Nervenarzt 1999;70: 1727.
  • 11
    Dulac O. Epilepsies et convulsions de l'enfant. Encyclopédie Médico-Chirurgicale. Paris : Elsevier, 1998: 126.
  • 12
    Dichter MA, Brodie MJ. New antiepileptic drugs. N Engl J Med 1996;334: 158390.
  • 13
    Pellock JM, Glauser TA, Bebin EM, et al. Pharmacokinetic study of levetiracetam in children. Epilepsia 2001;42: 15749.
  • 14
    Claassen J, Hirsch LJ, Emerson RG, et al. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia 2002;43: 14653.
  • 15
    Yoshikawa H, Yamazaki S, Abe T, et al. Midazolam as a first-line agent for status epilepticus in children. Brain Dev 2000;22: 23942.
  • 16
    Dreier JP, Zhang CL, Heinemann U. Phenytoin, phenobarbital, and midazolam fail to stop status epilepticus-like activity induced by low magnesium in rat entorhinal slices, but can prevent its development. Acta Neurol Scand 1998;98: 15460.
  • 17
    Zhang CL, Dreier JP, Heinemann U. Paroxysmal epileptiform discharges in temporal lobe slices after prolonged exposure to low magnesium are resistant to clinically used anticonvulsants. Epilepsy Res 1995;20: 10511.
  • 18
    Engel D, Endermann U, Frahm C, et al. Acute effects of gamma-vinyl-GABA on low-magnesium evoked epileptiform activity in vitro. Epilepsy Res 2000;40: 99107.
  • 19
    Musshoff U, Kohling R, Lucke A, et al. Vigabatrin reduces epileptiform activity in brain slices from pharmacoresistant epilepsy patients. Eur J Pharmacol 2000;401: 16772.
  • 20
    Schuchmann S, Buchheim K, Meierkord H, et al. A relative energy failure is associated with low-Mg2+ but not with 4-aminopyridine induced seizure-like events in entorhinal cortex. J Neurophysiol 1999;81: 399403.
  • 21
    Margineanu DG, Klitgaard H. Inhibition of neuronal hypersynchrony in vitro differentiates levetiracetam from classical antiepileptic drugs. Pharmacol Res 2000;42: 2815.
  • 22
    Pellock JM. Felbamate. Epilepsia 1999;40(suppl 5):S5762.
  • 23
    Pfeiffer M, Draguhn A, Meierkord H, et al. Effects of gamma-aminobutyric acid (GABA) agonists and GABA uptake inhibitors on pharmacosensitive and pharmacoresistant epileptiform activity in vitro. Br J Pharmacol 1996;119: 56977.
  • 24
    Sabau A, Frahm C, Pfeiffer M, et al. Age-dependence of the anticonvulsant effects of the GABA uptake inhibitor tiagabine in vitro. Eur J Pharmacol 1999;383: 25966.
  • 25
    Heinemann U, Zhang CL, Eder C. Entorhinal cortex-hippocampal interactions in normal and epileptic temporal lobe. Hippocampus 1993;3: 8997.
  • 26
    Ishizawa Y, Furuya K, Yamagishi S, et al. Non-GABAergic effects of midazolam, diazepam and flumazenil on voltage-dependent ion currents in NG108-15 cells. Neuroreport 1997;8: 26358.
  • 27
    Grunze H, Walden J. Reduction of the frequency of occurrence of low magnesium induced field potentials in the hippocampus slice preparation of guinea pigs: a good screening tool for calcium antagonistic effects of anticonvulsant and antipsychotic drugs. Magnes Res 1997;10: 11926.
  • 28
    Von Wegerer J, Hesslinger B, Berger M, et al. A calcium antagonistic effect of the new antiepileptic drug lamotrigine. Eur Neuropsychopharmacol 1997;7: 7781.
  • 29
    Libri V, Constanti A, Zibetti M, et al. Effects of felbamate on muscarinic and metabotropic-glutamate agonist-mediated responses and magnesium-free or 4-aminopyridine-induced epileptiform activity in guinea pig olfactory cortex neurons in vitro. J Pharmacol Exp Ther 1996;277: 175969.
  • 30
    Kwan P, Sills GJ, Brodie MJ. The mechanisms of action of commonly used antiepileptic drugs. Pharmacol Ther 2001;90: 2134.
  • 31
    Rho JM, Sankar R. The pharmacologic basis of antiepileptic drug action. Epilepsia 1999;40: 147183.
  • 32
    Pugliese AM, Passani MB, Pepeu G, et al. Felbamate decreases synaptic transmission in the CA1 region of rat hippocampal slices. J Pharmacol Exp Ther 1996;279: 11008.
  • 33
    Birnstiel S, Wulfert E, Beck SG. Levetiracetam (ucb LO59) affects in vitro models of epilepsy in CA3 pyramidal neurons without altering normal synaptic transmission. Naunyn Schmiedebergs Arch Pharmacol 1997;356: 6118.
  • 34
    Gibbs JW III, Sombati S, DeLorenzo RJ, et al. Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons. Epilepsia 2000;41(suppl 1):S106.
  • 35
    Overstreet LS, Westbrook GL. Paradoxical reduction of synaptic inhibition by vigabatrin. J Neurophysiol 2001;86: 596603.
  • 36
    Backus KH, Pflimlin P, Trube G. Action of diazepam on the voltage-dependent Na+ current: comparison with the effects of phenytoin, carbamazepine, lidocaine and flumazenil. Brain Res 1991;548: 419.
  • 37
    Wyllie E. Antiepileptic medications. The treatment of epilepsy: principles and practice. 3rd ed. Philadelphia : Lippincott Williams & Wilkins, 2001: 82168.